Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;10(1):1–15. doi: 10.1111/j.1750-3639.2000.tb00238.x

CD40L is Critical for Protection from Demyelinating Disease and Development of Spontaneous Remyelination in a Mouse Model of Multiple Sclerosis

Kristen M Drescher 1, Laurie J Zoecklein 1, Kevin D Pavelko 1, Cynthia Rivera‐Quinones 1, Diane Hollenbaugh 2, Moses Rodriguez 1,✉
PMCID: PMC8098531  PMID: 10668891

Abstract

Theiler's murine encephalomyelitis virus (TMEV) induces acute neuronal disease followed by chronic demyelination in susceptible strains of mice. In this study we examined the role of a limited immune defect (deletion or blocking of CD40 ligand [CD40L]) on the extent of brain disease, susceptibility to demyelination, and the ability of demyelinated mice to spontaneously remyelinate following TMEV infection. We demonstrated that CD40L‐dependent immune responses participate in pathogenesis in the cerebellum and the spinal cord white matter but protect the striatum of susceptible SJL/J mice. In mice on a background resistant to TMEV‐induced demyelination (C57BL/6), the lack of CD40L resulted in increased striatal disease and meningeal inflammation. In addition, CD40L was required to maintain resistance to demyelination and clinical deficits in H‐2 b mice. CD40L‐mediated interactions were also necessary for development of protective H‐2b‐restricted cytotoxic T cell responses directed against the VP2 region of TMEV as well as for spontaneous remyelination of the spinal cord white matter. The data presented here demonstrated the critical role of this molecule in both antibody‐ and cell‐mediated protective immune responses in distinct phases of TMEV‐mediated pathology.

Full Text

The Full Text of this article is available as a PDF (511.4 KB).

References

  • 1. Asakura K, Miller DJ, Pease LR, Rodriguez M (1998) Targeting of IgMk antibodies to oligodendrocytes promotes central nervous system remyelination. J Neurosci 18: 7700–7708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Aubert C, Chamorro M, Brahic M (1987) Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb Pathog 3: 319–326. [DOI] [PubMed] [Google Scholar]
  • 3. Azoulay A, Brahic M, Bureau JF (1994) FVB mice transgenic for the H‐2Db gene become resistant to persistent infection by Theiler's virus. J Virol 68: 4049–4052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR (1996) CD40 ligand is required for protective cell‐mediated immunity to Leishmania major. Immunity 4: 283–289. [DOI] [PubMed] [Google Scholar]
  • 5. Cash E, Bandeira A, Chirinian S, Brahic M (1989) Characterization of B lymphocytes present in the demyelinating lesionS induced by Theiler's virus. J Immunol 1989, 143:984–988. [PubMed] [Google Scholar]
  • 6. Cash E, Bandeira A (1991) Effector T lymphocytes present in demyelinating lesions induced by Theiler's virus. Viral Immunol 4: 53–57. [DOI] [PubMed] [Google Scholar]
  • 7. Clatch RJ, Melvold RW, Miller SD, Lipton HL (1985) Theiler's murine encephalomyelitis virus (TMEV)‐induced demyelinating disease in mice is influenced by the H‐2D region: correlation with TMEV‐specific delayed‐type hypersensitivity. J Immunol 135: 1408–141. [PubMed] [Google Scholar]
  • 8. Clatch RJ, Miller SD, Metzner R, Dal Canto MC, Lipton HL (1990) Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 176: 244–254. [DOI] [PubMed] [Google Scholar]
  • 9. Dal Canto MC, Lipton HL (1975) Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab Invest 33: 626–637. [PubMed] [Google Scholar]
  • 10. Dal Canto MC, Lipton HL (1982) Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am J Pathol 106: 20–29. [PMC free article] [PubMed] [Google Scholar]
  • 11. Drescher KM, Murray PD, David CS, Pease LR, Rodriguez M (1999) CNS cell populations are protected from virus‐induced pathology by distinct arms of the immune system. Brain Pathol 9: 21–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Drescher KM, Rivera‐Quinones C, Lucchinetti CF, Rodriguez M (1998) Failure of linomide or oral myelin tolerization to ameliorate demyelination in a viral model of multiple sclerosis. J Neuroimmunol 88: 111–119. [DOI] [PubMed] [Google Scholar]
  • 13. Durie FH, Fava RA, Foy FM, Arruffo A, Ledbetter JA, Noelle RJ (1993) Prevention of collagen‐induced arthritis with an antibody to gp39, the ligand for CD40. Science 261: 1328–1330. [DOI] [PubMed] [Google Scholar]
  • 14. Fiette L, Aubert C, Brahic M, Rossi CP (1993) Theiler's virus infection of beta 2‐microglobulin‐deficient mice. J Virol 67: 589–592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Fiette L, Aubert C, Muller U, Huang S, Auget M, Brahic M, Bureau JF (1995) Theiler's virus infection of 129 Sv mice that lack the interferon α/β or interferon γ receptors. J Exp Med 181: 2069–2076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Fiette L, Brahic M, Pena‐Rossi C (1996) Infection of class‐II deficient mice by the DA strain of Theiler's virus. J Virol 70: 4811–4815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Foy TM, Laman JD, Ledbetter JA, Aruffo A, Claassen E, Noelle RJ (1994) gp39‐CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med 180:157–163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Foy TM, Shepherd DM, Durie FH, Aruffo A, Ledbetter JA, Noelle RJ (1993) In vivo CD40‐gp39 interactions are essential for thymus‐dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J Exp Med 178: 1567–1575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Gerritse K, Laman JD, Noelle RJ, Arruffo A, Ledbetter JA, Boersma WJA, Claassen E (1996) CD40‐CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Nat Acad Sci USA 93: 2499–2504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Grewal IS, Flavell RA (1998) CD40 and CD154 in cell‐mediated immunity. Ann Rev Immunol 16: 111–135. [DOI] [PubMed] [Google Scholar]
  • 21. Howard LM, Miga AJ, Vanderlust CL, Dal Canto MC, Laman JD, Noelle RJ, Miller SD (1999) Mechanisms of immunotherapeutic intervention by anti‐CD40L (CD154) antibody in an animal model of multiple sclerosis. J Clin Invest 103:281–290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Johnson AJ, Njenga MK, Hansen MJ, Kuhns ST, Chen LP, Rodriguez M, Pease LR (1999) Prevalent class I‐restricted T‐cell response to the Theiler's virus epitope D‐b: VP2(121–130) in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J Virol 73: 3702–3708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Lang W, Rodriguez M, Lennon VA, Lampert, PW (1984) Demyelination and remyelination in murine viral encephalomyelitis. Ann NY Acad Sci 436: 98–102. [DOI] [PubMed] [Google Scholar]
  • 24. Lin X, Pease LR, Rodriguez M (1997) Differential generation of Class I H‐2D‐versus H‐2K‐restricted cytotoxicity against a demyelinating virus following central nervous system infection. Eur J Immunol 27: 963–970. [DOI] [PubMed] [Google Scholar]
  • 25. Lin X, Thiemann R, Pease LR, Rodriguez M (1995) VP1 and VP2 capsid proteins of Theiler's virus are targets of H‐2D‐restricted cytotoxic lymphocytes in the central nervous system of B10 mice. Virology 214: 91–99. [DOI] [PubMed] [Google Scholar]
  • 26. Lindsley MD, Patick AK, Prayoonwiwat N, Rodriguez M (1992) Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: a model for multiple sclerosis. Mayo Clin Proc 67: 829–838. [DOI] [PubMed] [Google Scholar]
  • 27. Lipton HL (1995) Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun 11:1147–1155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Lipton HL, Dal Canto MC (1979) Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus. Infect Immun 26: 369–374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Lipton HL, Dal Canto MC (1976) Theiler's virus‐induced demyelination: prevention by immunosuppression. Science 192: 62–64. [DOI] [PubMed] [Google Scholar]
  • 30. Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, Libby P (1997) Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40‐CD40 ligand signaling in atherosclerosis. Proc Nat Acad Sci USA 94: 1931–1936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Miller DJ, Rivera‐Quinones C, Njenga MK, Leibowitz J, Rodriguez, M (1995) Spontaneous CNS remyelination in β2 microglobulin‐deficient mice following virus‐induced demyelination. J Neurosci 8345–8352. [DOI] [PMC free article] [PubMed]
  • 32. Miller DJ, Sanborn KS, Katzmann JA, Rodriguez M (1994) Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 14: 6230–6238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Murray PD, McGavern DB, Lin X, Njenga MK, Leibowitz J, Pease LR, Rodriguez M (1998) Perforin‐dependent neurologic injury in a viral model of multiple sclerosis. J Neurosci 18: 7306–7314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Njenga MK, Hansen M.J, Kuhns ST, Chen LP, Rodriguez M, Pease LR (1999) Prevalent class I‐restricted T‐cell response to the Theiler's virus epitope Db: VP2 (121–130) in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J Virol 73: 3702–3708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Njenga MK, Pavelko KD, Baisch J, Lin X, David C, Leibowitz J, Rodriguez M (1996) Theiler's virus persistence and demyelination in major histocompatibility complex class II‐deficient mice. J Virol 70: 1729–1737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Oxenius A, Campbell KA, Maliszewski CR, Kishimoto T, Kikutani H, Hengartner H, Zinkernagel RM, Bachmann MF (1996) CD40‐CD40L interactions are critical in T‐B cooperation but not for other anti‐viral CD4+ T cell functions. J Exp Med 183: 2209–2218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Parker DC, Greiner DL, Phillips NE, Appel MC, Steele AW, Durie FH, Noelle RJ, Mordes JP, Rossini AA (1995) Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Nat Acad Sci USA 92: 9560–9564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Patick AK, Pease LR, David CS, Rodriguez M (1990) Major histocompatibility complex‐conferred resistance to Theiler's virus‐induced demyelinating disease is inherited as a dominant trait in B10 congenic mice. J Virol 64: 5570–5576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Pierce ML, Rodriguez M (1989) Erichrome stain for myelin on osmicated tissue embedded in glycol methacrylate plastic. J Histotech 12: 35–36. [Google Scholar]
  • 40. Rivera‐Quinones C, McGavern D, Schmelzer JD, Hunter SF, Low PA, and Rodriguez, M (1998) Absence of neurological deficits following extensive demyelination in a class I‐deficient murine model of multiple sclerosis. Nature Medicine 4: 187–193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Rodriguez M, David CS (1985) Demyelination induced by Theiler's virus: influence of the H‐2 haplotype. J Immunol 135:2145–2148. [PubMed] [Google Scholar]
  • 42. Rodriguez M, David CS (1995) H‐2 Dd transgene suppresses Theiler's virus‐induced demyelination in susceptible strains of mice. J Neurovirol 1: 111–117. [DOI] [PubMed] [Google Scholar]
  • 43. Rodriguez M, Dunkel AJ, Thiemann RL, Leibowitz J, Zijlstra M, Jaenisch R (1993) Abrogation of resistance to Theiler's virus‐induced demyelination in H‐2b mice deficient in β 2‐microglobulin. J Immunol 151: 266–276. [PubMed] [Google Scholar]
  • 44. Rodriguez M, Kenny JJ, Thiemann RL, Woloschak GE (1990) Theiler's virus‐induced demyelination in mice immunosuppressed with anti‐IgM and in mice expressing the xid gene. Microb Pathog 8: 23–35. [DOI] [PubMed] [Google Scholar]
  • 45. Rodriguez M, Lafuse W, Leibowitz J, David CS (1986) Partial suppression of Theiler's virus‐induced demyelination in vivo by administration of monoclonal antibodies to immune response gene products (Ia antigens). Neurol 36: 964–970. [DOI] [PubMed] [Google Scholar]
  • 46. Rodriguez M, Leibowitz JL, Lampert PW (1983) Persistent infection of oligodendrocytes in Theiler's virus‐induced encephalomyelitis. Ann Neurol 13: 426–433. [DOI] [PubMed] [Google Scholar]
  • 47. Rodriguez M, Leibowitz J, David CS (1986) Susceptibility to Theiler's Virus‐Induced demyelination: mapping of the gene within the H‐2D region. J Exp Med 163: 620–631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Rodriguez M, Lennon VA (1990) Immunoglobulins promote remyelination in the central nervous system. Ann Neurol 27: 12–17. [DOI] [PubMed] [Google Scholar]
  • 49. Rodriguez, M. , Lucchinetti, C. F. , Clark, R. J. , Yaksh, T. L. , Markowitz, H. , and Lennon VA (1988) Immunoglobulins and complement in demyelination induced in mice by Theiler's virus. J Immunol 140: 800–806. [PubMed] [Google Scholar]
  • 50. Rodriguez M, Miller DJ, Lennon VA (1996) Immunoglobulins reactive with myelin basic protein promotes CNS remyelination. Neurol 46: 538–545. [DOI] [PubMed] [Google Scholar]
  • 51. Rodriguez M, Nickerson C, Patick AK, David CS (1991) Expression of human HLA‐B27 transgene alters susceptibility to murine Theiler's virus‐induced demyelination. J Immunol 146: 2596–2602. [PubMed] [Google Scholar]
  • 52. Rodriguez M, Patick AK, Pease LR (1990) Abrogation of resistance to Theiler's virus‐induced demyelination in C57BL mice by total body irradiation. J Neuroimmunol 26: 189–199. [DOI] [PubMed] [Google Scholar]
  • 53. Rodriguez M, Pavelko KD, Coffman RL (1995) Gamma interferon is critical for resistance to Theiler's virus‐induced demyelination. J Virol 69: 7286–7290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Rodriguez M, Pedrinaci S, David CS (1993) Human class I major histocompatibility complex transgene prevents virus‐induced demyelination in susceptible mutant B10.D2dml mice. Ann Neurol 33: 208–212. [DOI] [PubMed] [Google Scholar]
  • 55. Rodriguez M, Sriram S (1998) Successful therapy of TMEV‐induced demyelination (DA strain) with monoclonal anti lyt2.2 antibody. J Immunol 140: 2950–2955. [PubMed] [Google Scholar]
  • 56. Rossi CP, McAllister A, Tanguay M, Kagi D, Brahic, M (1998) Theiler's virus infection of perforin‐deficient mice. J Virol 72: 4515–4519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Roos RP, Firestone S, Wollman R, Variakojis D, Arnason BGW (1982) The effect of short term and chronic immunosuppression on Theiler's virus demyelination. J Neuroimmunol 2: 223–234. [DOI] [PubMed] [Google Scholar]
  • 58. Thomsen AR, Nansen A, Christensen JP, Andreasen SO, Marker O (1998) CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus. J Immunol 161: 4583–4590. [PubMed] [Google Scholar]
  • 59. Traugott U, Stone SH, Raine CS (1982) Chronic relapsing experimental autoimmune encephalomyelitis. Treatment with combinations of myelin components promotes clinical and structural recovery. J Neurol Sci 56: 65–73. [DOI] [PubMed] [Google Scholar]
  • 60. Welsh CJR, Tonks P, Nash AA, Blakemore WF (1987) The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J Gen Virol 68: 1659–1667. [DOI] [PubMed] [Google Scholar]
  • 61. Wiley JA, Harmsen AG (1995) CD40 ligand is requuired for resolution of Pneumocystis carinii pneumonia in mice. J Immunol 155: 3525–3529. [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES